SKI Market

Indian Indices

Nifty

22,502.00 35.90
(0.16%)

Sensex

74,005.94 88.91
( 0.12%)

Bank Nifty

48,199.50 83.85
( 0.17%)

Nifty IT

33,438.75 56.90
( 0.17%)

Global Indices

Nasdaq

16,685.97 -12.35
(-0.07%)

Dow Jones

40,003.59 134.21
(0.34%)

Hang Seng

19,553.61 177.08
(0.91%)

Nikkei 225

38,787.38 -132.88
(-0.34%)

Forex

USD-INR

83.47 0.01
(0.01%)

EUR-INR

90.76 0.22
(0.25%)

GBP-INR

105.79 0.36
(0.34%)

JPY-INR

0.54 0.00
(0.51%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Krebs Biochemicals & Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524518

INE268B01013

-50.2613955

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

KREBSBIO

147.04

EPS(TTM)

Face Value()

Div & Yield %

Back

aadi industries ltd

Earum Pharmaceuticals standalone net profit declines 97.08% in the December 2023 quarter

Feb 15,2024

Net profit of Earum Pharmaceuticals declined 97.08% to Rs 0.04 crore in the quarter ended December 2023 as against Rs 1.37 crore during the previous quarter ended December 2022. Sales declined 65.81% to Rs 0.40 crore in the quarter ended December 2023 as against Rs 1.17 crore during the previous quarter ended December 2022.

Particulars	Quarter Ended
	Dec. 2023	Dec. 2022	% Var.
Sales	0.40	1.17	-66
OPM %	15.00	11.97	-
PBDT	0.06	1.40	-96
PBT	0.04	1.37	-97
NP	0.04	1.37	-97

22,502.00 35.90 (0.16%)

74,005.94 88.91 ( 0.12%)

48,199.50 83.85 ( 0.17%)

33,438.75 56.90 ( 0.17%)

16,685.97 -12.35 (-0.07%)

40,003.59 134.21 (0.34%)

19,553.61 177.08 (0.91%)

38,787.38 -132.88 (-0.34%)

83.47 0.01 (0.01%)

90.76 0.22 (0.25%)

105.79 0.36 (0.34%)

0.54 0.00 (0.51%)